Evidence map›Paper›PMID 36387031›Full record

ArticleSaudi journal of biological sciences2023

Shahid Shabbir Awan, Rizwan Taj Khan, Ansar Mehmood, Muhammad Hafeez, Syed Rizwan Abass, Munazza Nazir, Muhammad Raffi

Abstract read
In one paragraph

Article in Saudi journal of biological sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. UtilizingMolecules (Basel, Switzerland) · 2024
    Article
  12. Chia seed-mediated fabrication of ZnO/Ag/AgFrontiers in chemistry · 2024
    Article
  13. Article
  14. Green Synthesis of Silver Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shahid Shabbir AwanDepartment of Botany, University of Azad Jammu and Kashmir, Muzaffarabad, Azad Kashmir, Pakistan.
Rizwan Taj KhanDepartment of Botany, University of Azad Jammu and Kashmir, Muzaffarabad, Azad Kashmir, Pakistan.
Ansar MehmoodDepartment of Botany, University of Poonch Rawalakot, 12350 Azad Jammu and Kashmir, Pakistan.
Muhammad HafeezDepartment of Chemistry, University of Azad Jammu and Kashmir, Muzaffarabad, Azad Kashmir, Pakistan.
Syed Rizwan AbassDepartment of Biotechnology, Karakoram International University Gilgit, Pakistan.
Munazza NazirDepartment of Botany, University of Azad Jammu and Kashmir, Muzaffarabad, Azad Kashmir, Pakistan.
Muhammad RaffiDepartment of Materials Engineering, National Institute of Lasers and Optronics (NILOP), Lehtrar Road, Nilore, Islamabad 45650, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Fabricating zinc oxide nanoparticles (ZnO-NPs) from plant extracts is a cost-effective, safe, and environmentally friendly alternative to established chemical procedures. This study was aimed at the environmentally friendly fabrication of ZnO-NPs from plant extract. An additional objective was to investigate the antibacterial and antioxidant activity of these biosynthesized ZnO-NPs. Methods: ZnO-NPs were fabricated using the leaf extract of Results: A surface Plasmon peak was recorded at 327 nm, showing the existence of ZnO-NPs in the reaction solution of plant extract and zinc sulfate hexahydrate salt. These nanoparticles were predominantly spherical and capped by different functional groups of biomolecules. Furthermore, ZnO-NPs showed a dose-dependent antibacterial and antioxidant activity. At 20 mg/mL ZnO-NPs, the maximum bactericidal potential of ZnO-NPs was reported against Conclusion: This research presents an environmentally acceptable method for producing spherical ZnO-NPs with high antibacterial and antioxidant activities. These bio-fabricated ZnO-NPs could be a good option for applications in medicine and the healthcare industry.

Indexed as

Ailanthus altissimaAntibacterial activityAntioxidant activityNanopartilcesZnO

Identifiers

PMID36387031
PMCPMC9649943

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.